Extract
It should have been a wake-up call. Thirty years ago, Tomlinsonand Sahn[1] found that seven out of 12 (58%) patients with aspergillosis complicating sarcoidosis died over a 2 year period. Three years earlier, Wollschlagerand Khan[2] had found evidence of aspergillosis in 12% of 100 consecutive sarcoidosis referrals, and aspergillomas were found in 53% of the 19 patients with fibrocystic aspergillosis. Yet the literature was almost silent on this topic despite an estimated global prevalence of 1.2 million patients with sarcoidosis [3], until 2008. In that year, Hourset al.[4] surveyed pulmonary cavitary sarcoidosis and its complications in their tertiary care service for sarcoidosis in Paris, France. They found that 3.9% had cavitary lesions and 2.1% an aspergilloma. This team have followed that report up in this issue of theEuropean Respiratory Journalwith a detailed study of chronic pulmonary aspergillosis complicating pulmonary sarcoidosis [5]. Others have noted the complexity of this dual pulmonary condition [6].
一个bstract
CPA is a serious complication of sarcoidosis contributing to fibrosis, respiratory failure and haemoptysishttp://ow.ly/cMyQ30bNG4z
Footnotes
Conflict of interest: Disclosures can be found alongside this article atwww.qdcxjkg.com
- ReceivedMarch 19, 2017.
- 一个cceptedMarch 21, 2017.
- Copyright ©ERS 2017